US › Healthcare

InterCure Ltd. (INCR)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$5.310.00%

Last close · 2026-09-17

Latest quarter · ended 2026-03-31

Revenue

$70.1M

Revenue YoY

+23.9%

Net profit

$-17.0M

EPS

$0.00

EPS estimate

$0.05

Net margin

-24.3%

EPS came in at 0.00 against a street estimate of 0.05 — a miss of 100.0%.

Key statistics

Market cap

$77.4M

Forward P/E

6.2

P/B

0.60

Book value

$7.59

EPS (TTM)

$-1.09

52-week high

$8.45

52-week low

$3.40

50-day MA

$4.96

200-day MA

$4.80

Beta

0.59

Analyst view

with an average price target of $33.56.

Shareholding

Insiders

39.17%

Institutions

1.05%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for InterCure Ltd. — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.